LS-C99185

antibody from LSBio

Targeting: PRKN AR-JP, PARK2, parkin, PDJ

Western blot

Immunocytochemistry

Antibody data

Submit

Validation data

Product number: LS-C99185 - Provider product page
Provider: LSBio
Proper citation: LifeSpan Cat#LS-C99185, RRID:AB_2159948
Product name: PARK2 / Parkin 2 Antibody (aa387-417) LS-C99185
Antibody type: Polyclonal
Description: Ammonium sulfate precipitation
Reactivity: Human
Host: Rabbit
Storage: Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.

PRKN protein structure - LS-C99185 shown in red.

Supportive validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human testis tissue reacted with PARK2 (Parkin) antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human testis tissue reacted with PARK2 (Parkin) antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.